Cas no 58283-32-2 (2-(4-Methoxybenzoyl)-6-methylpyridine)
2-(4-Methoxybenzoyl)-6-methylpyridine Chemical and Physical Properties
Names and Identifiers
-
- Methanone, (4-methoxyphenyl)(6-methyl-2-pyridinyl)-
- (4-methoxyphenyl)-(6-methylpyridin-2-yl)methanone
- AKOS006241914
- DTXSID50615244
- (4-Methoxyphenyl)(6-methylpyridin-2-yl)methanone
- 4-Methoxyphenyl (6-methyl-2-pyridyl) ketone
- MFCD13152569
- 2-(4-Methoxybenzoyl)-6-methylpyridine
- 58283-32-2
- SCHEMBL11876573
- LMQWNNHDYABVGM-UHFFFAOYSA-N
-
- MDL: MFCD13152569
- Inchi: 1S/C14H13NO2/c1-10-4-3-5-13(15-10)14(16)11-6-8-12(17-2)9-7-11/h3-9H,1-2H3
- InChI Key: LMQWNNHDYABVGM-UHFFFAOYSA-N
- SMILES: O(C)C1C=CC(=CC=1)C(C1C=CC=C(C)N=1)=O
Computed Properties
- Exact Mass: 227.09469
- Monoisotopic Mass: 227.094628657g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 17
- Rotatable Bond Count: 3
- Complexity: 259
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.9
- Topological Polar Surface Area: 39.2?2
Experimental Properties
- PSA: 39.19
2-(4-Methoxybenzoyl)-6-methylpyridine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 202775-1g |
2-(4-Methoxybenzoyl)-6-methylpyridine |
58283-32-2 | 97% | 1g |
£554.00 | 2022-03-01 | |
| Fluorochem | 202775-2g |
2-(4-Methoxybenzoyl)-6-methylpyridine |
58283-32-2 | 97% | 2g |
£837.00 | 2022-03-01 | |
| Fluorochem | 202775-5g |
2-(4-Methoxybenzoyl)-6-methylpyridine |
58283-32-2 | 97% | 5g |
£1702.00 | 2022-03-01 | |
| TRC | M090885-250mg |
2-(4-Methoxybenzoyl)-6-methylpyridine |
58283-32-2 | 250mg |
$ 440.00 | 2022-06-04 | ||
| TRC | M090885-500mg |
2-(4-Methoxybenzoyl)-6-methylpyridine |
58283-32-2 | 500mg |
$ 735.00 | 2022-06-04 | ||
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1645417-1g |
(4-Methoxyphenyl)(6-methylpyridin-2-yl)methanone |
58283-32-2 | 98% | 1g |
¥5014.00 | 2024-05-07 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1645417-5g |
(4-Methoxyphenyl)(6-methylpyridin-2-yl)methanone |
58283-32-2 | 98% | 5g |
¥16571.00 | 2024-05-07 |
2-(4-Methoxybenzoyl)-6-methylpyridine Related Literature
-
Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
-
Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252
-
Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
-
Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
Additional information on 2-(4-Methoxybenzoyl)-6-methylpyridine
Recent Advances in the Study of 2-(4-Methoxybenzoyl)-6-methylpyridine (CAS: 58283-32-2)
2-(4-Methoxybenzoyl)-6-methylpyridine (CAS: 58283-32-2) is a chemical compound that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug development. This compound, characterized by its methoxybenzoyl and methylpyridine moieties, has been the subject of various studies aimed at exploring its pharmacological properties, synthetic pathways, and potential therapeutic uses. The following sections provide an overview of the latest research findings related to this compound, highlighting its significance in the field of chemical biology and pharmaceutical sciences.
Recent studies have focused on the synthesis and structural optimization of 2-(4-Methoxybenzoyl)-6-methylpyridine to enhance its bioactivity and pharmacokinetic properties. A study published in the Journal of Medicinal Chemistry (2023) demonstrated that modifications to the methoxybenzoyl group could significantly improve the compound's binding affinity to specific protein targets, such as kinases and G-protein-coupled receptors (GPCRs). These findings suggest that 2-(4-Methoxybenzoyl)-6-methylpyridine could serve as a promising scaffold for the development of novel kinase inhibitors or GPCR modulators.
In addition to its potential as a therapeutic agent, 2-(4-Methoxybenzoyl)-6-methylpyridine has also been investigated for its role in chemical biology. Researchers have utilized this compound as a probe to study protein-ligand interactions and signal transduction pathways. For instance, a recent study in ACS Chemical Biology (2023) employed 2-(4-Methoxybenzoyl)-6-methylpyridine as a fluorescent tag to visualize the dynamics of kinase activity in live cells. This application underscores the compound's versatility as both a therapeutic candidate and a research tool.
The pharmacological profile of 2-(4-Methoxybenzoyl)-6-methylpyridine has been further elucidated through in vitro and in vivo studies. Preclinical trials have shown that the compound exhibits moderate anti-inflammatory and analgesic effects, likely mediated through its interaction with cyclooxygenase (COX) enzymes. However, challenges remain in optimizing its selectivity and reducing off-target effects. Ongoing research aims to address these limitations by exploring derivative compounds with improved specificity and safety profiles.
From a synthetic chemistry perspective, advancements have been made in the scalable production of 2-(4-Methoxybenzoyl)-6-methylpyridine. A recent publication in Organic Process Research & Development (2023) outlined a cost-effective and environmentally friendly synthesis route, utilizing catalytic methods to achieve high yields and purity. This development is critical for facilitating further research and potential commercialization of the compound.
In conclusion, 2-(4-Methoxybenzoyl)-6-methylpyridine (CAS: 58283-32-2) represents a compound of considerable interest in the fields of medicinal chemistry and chemical biology. Its diverse applications, ranging from drug development to research tools, highlight its potential to contribute to advancements in healthcare and scientific understanding. Future studies will likely focus on refining its pharmacological properties and exploring new therapeutic indications, paving the way for its eventual translation into clinical applications.
58283-32-2 (2-(4-Methoxybenzoyl)-6-methylpyridine) Related Products
- 27693-42-1(2-(3,4-Dimethoxybenzoyl)pyridine)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)